KCM
RYTM icon

Kennedy Capital Management’s Rhythm Pharmaceuticals RYTM Stock Holding History

Kennedy Capital Management’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.72M Buy
65,818
+25,931
+65% +$2.52M 0.12% 260
2025
Q4 		$4.27M Buy
39,887
+312
+0.8% +$33.1K 0.09% 324
2025
Q3 		$4M Sell
39,575
-17,642
-31% -$1.64M 0.09% 330
2025
Q2 		$3.62M Buy
57,217
+2,287
+4% +$140K 0.09% 344
2025
Q1 		$2.91M Buy
+54,930
New +$3.05M 0.07% 373
2024
Q3 		– Sell
-11,154
Closed -$458K – 727
2024
Q2 		$458K Buy
+11,154
New +$445K 0.01% 641

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Kennedy Capital Management's RYTM Position: Q1 2026 in Review

Kennedy Capital Management increased its Rhythm Pharmaceuticals (RYTM) stake by 65% in Q1 2026, buying an estimated $2.52M and bringing the position to 65,818 shares worth $5.72M. The position accounts for 0.12% of the portfolio, ranked #260.

Kennedy Capital Management first reported a position in RYTM in Q2 2024 and has held it in 6 quarters since. 285 funds tracked by Wall St. Rank hold RYTM as of Q1 2026.

  • Kennedy Capital Management held 65,818 shares of Rhythm Pharmaceuticals worth $5.72M as of Q1 2026.
  • Kennedy Capital Management bought 25,931 Rhythm Pharmaceuticals shares in Q1 2026, an estimated $2.52M.
  • Rhythm Pharmaceuticals made up 0.12% of Kennedy Capital Management's portfolio in Q1 2026, its #260 holding.
  • Kennedy Capital Management first reported a position in Rhythm Pharmaceuticals in Q2 2024 and has held it in 6 quarters since.
  • 285 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q1 2026.

Based on Kennedy Capital Management's 13F filing for Q1 2026, filed 13 May 2026.